Melatonin regulates mitochondrial dynamics and alleviates neuron damage in prion diseases.

Aging
Xixi ZhangLifeng Yang

Abstract

Prion diseases are neurodegenerative diseases associated with neuron damage and behavioral disorders in animals and humans. Melatonin is a potent antioxidant and is used to treat a variety of diseases. We investigated the neuroprotective effect of melatonin on prion-induced damage in N2a cells. N2a cells were pretreated with 10 μM melatonin for 1 hour followed by incubation with 100 μM PrP106-126 for 24 hours. Melatonin markedly alleviated PrP106-126-induced apoptosis of N2a cells, and inhibited PrP106-126-induced mitochondrial abnormality and dysfunction, including mitochondrial fragmentation and overproduction of reactive oxygen species (ROS), suppression of ATP, reduced mitochondrial membrane potential (MMP), and altered mitochondrial dynamic proteins dynamin-related protein 1 (DRP1) and optic atrophy protein 1 (OPA1). Our findings identify that pretreatment with melatonin prevents the deleterious effects of PrPSc on mitochondrial function and dynamics, protects synapses and alleviates neuron damage. Melatonin could be a novel and effective medication in the therapy of prion diseases.

References

Jan 15, 1994·FEMS Microbiology Letters·D W FairbairnK L O'Neill
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·R ChiesaD A Harris
Oct 6, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Erik I CharychBonnie L Firestein
Jun 24, 2008·Nature Reviews. Neuroscience·Andrew B KnottElla Bossy-Wetzel
Jul 8, 2008·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Indrajit ChowdhuryGanapathy K Bhat
Jul 9, 2009·Physiological Reviews·Marc LiesaAntonio Zorzano
Aug 13, 2010·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Richard Kones
Aug 21, 2010·EMBO Reports·Silvia Campello, Luca Scorrano
Aug 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Karen M DaviesWerner Kühlbrandt
Mar 20, 2012·Cell·Yadong Huang, Lennart Mucke
Jun 6, 2012·Oxidative Medicine and Cellular Longevity·Sergio Rosales-CorralRussel J Reiter
May 7, 2013·Neurobiology of Aging·Stanislaw MitewJames C Vickers
Jul 17, 2013·International Journal of Molecular Sciences·Li LinQing Tian
Dec 27, 2013·International Journal of Cell Biology·Assunta SenatoreRoberto Chiesa
May 5, 2016·Apoptosis : an International Journal on Programmed Cell Death·Selene García de la Cadena, Lourdes Massieu
Nov 23, 2016·CNS Neuroscience & Therapeutics·Mojtaba GolpichAbolhassan Ahmadiani
Aug 10, 2017·Cellular and Molecular Life Sciences : CMLS·Pawaris Wongprayoon, Piyarat Govitrapong
Sep 3, 2017·Cellular and Molecular Life Sciences : CMLS·Russel J ReiterBing Xu
May 2, 2018·Journal of Alzheimer's Disease : JAD·Yan ShiQing Tian
Aug 10, 2018·Ageing Research Reviews·Maryam MajidiniaBahman Yousefi
Oct 18, 2018·Journal of Pineal Research·Jose A BogaAna Coto-Montes
Oct 28, 2018·Neurologic Clinics·Boon Lead TeeMichael D Geschwind
Nov 9, 2018·Mitochondrion·Komal Panchal, Anand Krishna Tiwari
Jan 9, 2019·Frontiers in Cellular Neuroscience·Stephanie Ziegler-Waldkirch, Melanie Meyer-Luehmann
Jan 13, 2019·Neuropathology and Applied Neurobiology·G ForloniF Tagliavini
Mar 16, 2019·Current Opinion in Neurobiology·Meghan J Rossi, Gulcin Pekkurnaz

❮ Previous
Next ❯

Methods Mentioned

BETA
confocal microscopy
flow cytometry
fluorescence microscopy
transgenic
Assay

Software Mentioned

Quantity One
GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.